Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Hypertension

  Free Subscription


Articles published in Clin Exp Hypertens

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    December 2025
  1. SU Y, Zhang M, Xu P, Wen P, et al
    Genetic causal assessment between major depression and hypertension: A two-sample bidirectional Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2553507.
    PubMed     Abstract available


  2. SUN Z, Dai G, Quan N
    Hypertension accelerates aging: Evidence from NHANES database and Mendelian randomization analyses.
    Clin Exp Hypertens. 2025;47:2559743.
    PubMed     Abstract available


  3. JIANG G, Li X, Fang Z, Shi G, et al
    miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1.
    Clin Exp Hypertens. 2025;47:2561235.
    PubMed     Abstract available


  4. ZHOU J, Su Y, He L, Ding N, et al
    Association of different diet quality scores with cardiovascular disease mortality risk in hypertension treatment group.
    Clin Exp Hypertens. 2025;47:2563779.
    PubMed     Abstract available


  5. CHEN L, Wang X, Luo L, Li Y, et al
    The effect of comprehensive intervention on children with anxiety/depression and increased blood pressure.
    Clin Exp Hypertens. 2025;47:2560635.
    PubMed     Abstract available


  6. TIAN X, Zou Y, Zhou Y, Zhang Y, et al
    Investigating non-invasive hemodynamic indicators in hypertension patients with coronary atherosclerotic heart disease.
    Clin Exp Hypertens. 2025;47:2564296.
    PubMed     Abstract available


  7. SONG H, Li J, Lan L, Meng H, et al
    The causal relationship between aspartate aminotransferase and hypertension: A bidirectional Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2564298.
    PubMed     Abstract available


  8. TANAKA M, Akiyama Y, Mori K, Hosaka I, et al
    Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study.
    Clin Exp Hypertens. 2025;47:2449613.
    PubMed     Abstract available


  9. ZHANG K, Deng X, Li Z, Yi C, et al
    Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism.
    Clin Exp Hypertens. 2025;47:2457768.
    PubMed     Abstract available


  10. YANG H, Xing H, Zou X, Jin M, et al
    Efficacy and safety of intensive blood pressure control in patients over 60 years: A systematic review and meta-analysis.
    Clin Exp Hypertens. 2025;47:2465399.
    PubMed     Abstract available


  11. HAN JH, Sharapatov Y, Do MT, Kim SY, et al
    Safety and efficacy of extravascular renal denervation using HyperQure renal denervation system in short-term swine model of hypertension.
    Clin Exp Hypertens. 2025;47:2474520.
    PubMed     Abstract available


  12. ZHANG J, Zhang W, Yang Z, Fan B, et al
    Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway.
    Clin Exp Hypertens. 2025;47:2486829.
    PubMed     Abstract available


  13. HUANG Y, Li Z, Zhu J, Xiao L, et al
    Construction of a risk prediction model for adverse pregnancy outcomes in primipara with gestational diabetes mellitus combined with pregnancy-induced hypertension syndrome.
    Clin Exp Hypertens. 2025;47:2492621.
    PubMed     Abstract available


  14. WU D, Xiong J, Huang Y, Yuan Y, et al
    Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications.
    Clin Exp Hypertens. 2025;47:2500383.
    PubMed     Abstract available


  15. XU J, Zhao J, Gu J, Wang W, et al
    Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis.
    Clin Exp Hypertens. 2025;47:2496514.
    PubMed     Abstract available


  16. LIU X, Tan X, Su Y, Zou L, et al
    Anthocyanin attenuates pulmonary arterial hypertension and associated heart failure via improving mitochondrial function through Nrf2-dependent mechanism.
    Clin Exp Hypertens. 2025;47:2503805.
    PubMed     Abstract available


  17. GUO S, Su Y, Li Y, Li C, et al
    The causal relationship between circulating metabolites and gestational hypertension, pre-eclampsia, eclampsia: A bidirectional two-sample Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2508787.
    PubMed     Abstract available


  18. YESILDAG M, Duksal F
    Comorbidities and anthropometric parameters in obstructive sleep apnea syndrome: a phenotype-based study.
    Clin Exp Hypertens. 2025;47:2512136.
    PubMed     Abstract available


  19. XU Y, Deng C, Liang X
    Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension.
    Clin Exp Hypertens. 2025;47:2512130.
    PubMed     Abstract available


  20. HUANG X, Hu W, Chen L, Ma L, et al
    Mechanistic study of the association between microRNA-126 and hypertension in obstructive sleep apnea-hypopnea syndrome.
    Clin Exp Hypertens. 2025;47:2511056.
    PubMed     Abstract available


  21. BIRD GS, Lin YP, Tucker CJ, Mueller G, et al
    L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure.
    Clin Exp Hypertens. 2025;47:2515924.
    PubMed     Abstract available


  22. CHEN X, Sun L, Xuan K, Zong A, et al
    The role of immune mechanisms in hypertension and advances in immunomodulatory research.
    Clin Exp Hypertens. 2025;47:2535328.
    PubMed     Abstract available


    December 2024
  23. LAN C, Fang G, Qiu C, Li X, et al
    Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
    Clin Exp Hypertens. 2024;46:2297642.
    PubMed     Abstract available


  24. SUN Y, Shang Q
    Research hotspots and trends regarding microRNAs in hypertension: a bibliometric analysis.
    Clin Exp Hypertens. 2024;46:2304017.
    PubMed     Abstract available


  25. HE C, Li R, Yang J, Shen H, et al
    Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study.
    Clin Exp Hypertens. 2024;46:2301571.
    PubMed     Abstract available


  26. YUAN Y, Shi J, Sun W, Kong X, et al
    The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China.
    Clin Exp Hypertens. 2024;46:2303999.
    PubMed     Abstract available


  27. LIU Y, Lv Z, Zhou S, Fu Z, et al
    A smartwatch sphygmomanometer-based model for predicting short-term new-onset hypertension in individuals with high-normal blood pressure: a cohort study.
    Clin Exp Hypertens. 2024;46:2304023.
    PubMed     Abstract available


  28. LU J, Li Z, Yang Y, Wei F, et al
    Chronic exercise improves renal AT(1) and ETB receptor functions via modulating GRK4 expression in obese Zucker rats.
    Clin Exp Hypertens. 2024;46:2323532.
    PubMed     Abstract available


  29. DENG X, Luo H, He J, Deng W, et al
    Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKalpha signaling.
    Clin Exp Hypertens. 2024;46:2332695.
    PubMed     Abstract available


  30. YANG C, Song Y, Wang P
    Relationship between triglyceride-glucose index and new-onset hypertension in general population-a systemic review and meta-analysis of cohort studies.
    Clin Exp Hypertens. 2024;46:2341631.
    PubMed     Abstract available


  31. REN F, Yang M, Liu G, Qi Y, et al
    SIRT5-mediated PRKAA2 succinylation ameliorates apoptosis of human placental trophoblasts in hypertensive disorder complicating pregnancy.
    Clin Exp Hypertens. 2024;46:2358030.
    PubMed     Abstract available


  32. XU W, Gao X, Luo H, Chen Y, et al
    FGF21 attenuates salt-sensitive hypertension via regulating HNF4alpha/ACE2 axis in the hypothalamic paraventricular nucleus of mice.
    Clin Exp Hypertens. 2024;46:2361671.
    PubMed     Abstract available


  33. LIU S, Zhang H, Wu M, Zhou Z, et al
    Association between the triglyceride-glucose index and carotid artery plaque burden in patients with primary hypertension: A cross-sectional study.
    Clin Exp Hypertens. 2024;46:2383232.
    PubMed     Abstract available


  34. YIN L, Zhang X, Zhang H, Li R, et al
    Analysis of the current status and associated risk factors of cognitive function in Tibetan hypertensive patients at various altitudes.
    Clin Exp Hypertens. 2024;46:2393331.
    PubMed     Abstract available


  35. YANG L, Zhu X, Zhu J, Hu Z, et al
    Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring.
    Clin Exp Hypertens. 2024;46:2402260.
    PubMed     Abstract available


  36. MAO J, Zhang X, Wang C, Peng S, et al
    Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
    Clin Exp Hypertens. 2024;46:2402258.
    PubMed     Abstract available


    December 2023
  37. WANG Y, Xia M, Lu J, Wang T, et al
    TIP60 mediates stress-induced hypertension via promoting glutamate(dmPFC-)(to-)(vCA1) release.
    Clin Exp Hypertens. 2023;45:2259130.
    PubMed     Abstract available


  38. CAI X, Song S, Hu J, Zhu Q, et al
    Body roundness index improves the predictive value of cardiovascular disease risk in hypertensive patients with obstructive sleep apnea: a cohort study.
    Clin Exp Hypertens. 2023;45:2259132.
    PubMed     Abstract available


  39. WU W, Chen Y, Wu K, Zheng H, et al
    Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study.
    Clin Exp Hypertens. 2023;45:2264540.
    PubMed     Abstract available


  40. HU S, Zhang Y, Qiu C, Li Y, et al
    RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
    Clin Exp Hypertens. 2023;45:2271186.
    PubMed     Abstract available


  41. PANG J, Qian L, Che X, Lv P, et al
    TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension.
    Clin Exp Hypertens. 2023;45:2272581.
    PubMed     Abstract available


  42. YU W, Zhang Q, Qiu Y, Chen H, et al
    CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
    Clin Exp Hypertens. 2023;45:2272062.
    PubMed     Abstract available


  43. ZHOU X, Zhang L, Lin X, Chen X, et al
    Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na(+) excretion and insulin resistance.
    Clin Exp Hypertens. 2023;45:2276029.
    PubMed     Abstract available


  44. HUA R, Liu B, He W, Zhang H, et al
    Calcitriol reverses age-related hypertension via downregulating renal AP1/AT(1)R pathway through regulating mitochondrial function.
    Clin Exp Hypertens. 2023;45:2277653.
    PubMed     Abstract available


  45. TANG L, Cai Q, Wang X, Li X, et al
    Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
    Clin Exp Hypertens. 2023;45:2278205.
    PubMed     Abstract available


  46. LIU H, Li Y, Li M, Xie L, et al
    Follistatin-like 1 protects endothelial function in the spontaneously hypertensive rat by inhibition of endoplasmic reticulum stress through AMPK-dependent mechanism.
    Clin Exp Hypertens. 2023;45:2277654.
    PubMed     Abstract available


  47. TIAN X, Feng J, Chen S, Zhang Y, et al
    Baseline and longitudinal cardiovascular health using Life's Essential 8 metrics with the risk of incident hypertension.
    Clin Exp Hypertens. 2023;45:2271190.
    PubMed     Abstract available


  48. YANG J, Jiang G, Huang L, Liu Z, et al
    The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145-5p/HK2 in hypertension.
    Clin Exp Hypertens. 2023;45:2284658.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.